ATLAS fair value
€17.07
Below fair value · 39% discount
Revenio stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Nasdaq Helsinki · Finland
Prices as of Oct 27, 2026 · EUR
€17.07
Below fair value · 39% discount
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Revenio's fair value at about €17.07 per share (reasonable range: €10.17 to €28.84). At €10.36, the stock trades 39% below it.
It is calculated with a discounted cash-flow model. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Revenio a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €9.22 and €11.41; in 9 out of 10, between €7.63 and €13.79. Estimated annual volatility is 68%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Revenio sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks REG1V.HE has traded between €10.22 and €30.87. Today it is 66.4% below that high and 1% above its low.
On the business: net margin is 10.5%; it trades at 26.8 times earnings.
Its beta is 0.92: it moves roughly in line with the market.
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.
Want to see everything about Revenio?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About €17.07 per share according to ATLAS (reasonable range: €10.17 to €28.84). With the stock at €10.36, it is 39% below it.
47%: close to a coin flip. In half of the simulated outcomes, REG1V.HE ends the month between €9.22 and €11.41.
Revenio's market capitalization is €403M. Its price-to-earnings (P/E) ratio is 26.8: you pay €26.8 for each €1.00 of yearly earnings.
ATLAS estimates annual volatility at 68%. In a typical month, half of the outcomes end between €9.22 and €11.41.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy